UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004320
Receipt number R000005174
Scientific Title Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound
Date of disclosure of the study information 2010/10/04
Last modified on 2012/09/27 16:20:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound

Acronym

Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound

Scientific Title

Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound

Scientific Title:Acronym

Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound

Region

Japan


Condition

Condition

Hypertension, Coronary artery disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of intensive blood pressure control on progression of atherosclerosis by intravascular ultrasound.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The change of percent atheroma volume evaluated by intravascular ultrasound after 18 months.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intensive blood pressure control (SBP<120mmHg)

Interventions/Control_2

Standard blood pressure control (SBP<140mmHg)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1)Patients who are planning to take CAG or PCI.
2)Patients with primary hypertention: SBP140-180mmHg within one month.
3)20<=Age<80

Key exclusion criteria

1)Patients with severe hypertention.
2)Patients with secondary hypertension.
3)Patients treated hypertention with more than 3 drugs.
4)Patients with coronary artery disease in left main trank.
5)Patients with moderate heart failure.
6)Patients with severe valvelar disease.
7)Patients with liver dysfunction.
8)Patients with renal dysfuction(Cr>=2.0 mg/dL).
9)Pregnant or nursing woman.
10)Patients with uncontrollable arrythmia.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takeshi Kimura

Organization

Kyoto University

Division name

Cardiovascular Medicine

Zip code


Address

54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kyoto University

Division name

Cardiovascular Meicine

Zip code


Address


TEL

0757514255

Homepage URL


Email



Sponsor or person

Institute

Cardiovascular Medicine, Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Research Institute for Production Development

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2010 Year 09 Month 15 Day

Date of IRB


Anticipated trial start date

2010 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 10 Month 04 Day

Last modified on

2012 Year 09 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005174


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name